These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31725294)

  • 1. Insights to the Binding of a Selective Adenosine A
    Lagarias P; Barkan K; Tzortzini E; Stampelou M; Vrontaki E; Ladds G; Kolocouris A
    J Chem Inf Model; 2019 Dec; 59(12):5183-5197. PubMed ID: 31725294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of novel adenosine A
    Barkan K; Lagarias P; Stampelou M; Stamatis D; Hoare S; Safitri D; Klotz KN; Vrontaki E; Kolocouris A; Ladds G
    Sci Rep; 2020 Nov; 10(1):20781. PubMed ID: 33247159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Characterization of Agonist Binding to an A
    Stamatis D; Lagarias P; Barkan K; Vrontaki E; Ladds G; Kolocouris A
    J Med Chem; 2019 Oct; 62(19):8831-8846. PubMed ID: 31502843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor.
    Haeusler D; Grassinger L; Fuchshuber F; Hörleinsberger WJ; Höftberger R; Leisser I; Girschele F; Shanab K; Spreitzer H; Gerdenitsch W; Hacker M; Wadsak W; Mitterhauser M
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):928-39. PubMed ID: 25739834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.
    Huang X; Chorianopoulou A; Kalkounou P; Georgiou M; Pousias A; Davies A; Pearce A; Harris M; Lambrinidis G; Marakos P; Pouli N; Kolocouris A; Lougiakis N; Ladds G
    J Med Chem; 2024 Aug; 67(15):13117-13146. PubMed ID: 39073853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure-Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations.
    Stampelou M; Suchankova A; Tzortzini E; Dhingra L; Barkan K; Lougiakis N; Marakos P; Pouli N; Ladds G; Kolocouris A
    J Med Chem; 2022 Oct; 65(19):13305-13327. PubMed ID: 36173355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor.
    Kim SK; Riley L; Abrol R; Jacobson KA; Goddard WA
    Proteins; 2011 Jun; 79(6):1878-97. PubMed ID: 21488099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-driven identification of novel human A₃ adenosine receptor antagonists as potential therapeutic agents.
    Paoletta S; Federico S; Spalluto G; Moro S
    Methods Enzymol; 2010; 485():225-44. PubMed ID: 21050920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free-Energy Calculations for Bioisosteric Modifications of A
    Jandova Z; Jespers W; Sotelo E; Gutiérrez-de-Terán H; Oostenbrink C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Nitrogen Atom Substitution in A
    Azuaje J; Jespers W; Yaziji V; Mallo A; Majellaro M; Caamaño O; Loza MI; Cadavid MI; Brea J; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
    J Med Chem; 2017 Sep; 60(17):7502-7511. PubMed ID: 28792759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Covalent, Clickable Probes for Adenosine A
    Trinh PNH; Chong DJW; Leach K; Hill SJ; Tyndall JDA; May LT; Vernall AJ; Gregory KJ
    J Med Chem; 2021 Jun; 64(12):8161-8178. PubMed ID: 34120444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S
    J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.
    Ciancetta A; Jacobson KA
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats.
    Li P; Li X; Deng P; Wang D; Bai X; Li Y; Luo C; Belguise K; Wang X; Wei X; Xia Z; Yi B
    Aging (Albany NY); 2020 Nov; 13(1):694-713. PubMed ID: 33253120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Optimization of Coumarin hA
    Matos MJ; Vilar S; Vazquez-Rodriguez S; Kachler S; Klotz KN; Buccioni M; Delogu G; Santana L; Uriarte E; Borges F
    J Med Chem; 2020 Mar; 63(5):2577-2587. PubMed ID: 31738058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A3 adenosine receptor: homology modeling and 3D-QSAR studies.
    Almerico AM; Tutone M; Pantano L; Lauria A
    J Mol Graph Model; 2013 May; 42():60-72. PubMed ID: 23567933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
    Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
    Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonists.
    Azuaje J; Carbajales C; González-Gómez M; Coelho A; Caamaño O; Gutiérrez-de-Terán H; Sotelo E
    Future Med Chem; 2015; 7(11):1373-80. PubMed ID: 26230877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
    Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR
    Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.